Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dmytro Lopin"'
Autor:
Dmytro Volkov, MD, DMedSc, Dmytro Lopin, MD, Dmytro Skoriy, MD, Carola Gianni, MD, PhD, Vincenzo Mirko La Fazia, MD, G. Joseph Gallinghouse, MD, Rodney Horton, MD, John D. Burkhardt, MD, Sanghamitra Mohanty, MD, MS, Andrea Natale, MD
Publikováno v:
JACC: Case Reports, Vol 29, Iss 5, Pp 102227- (2024)
We present a case of persistent complete atrioventricular block that occurred during the diagnostic portion of a premature ventricular contractions’ radiofrequency ablation in a complex heart failure patient. The case was managed by bailout deep le
Externí odkaz:
https://doaj.org/article/32fc99bbe3eb46a3a305314d7c830a23
Publikováno v:
EMERGENCY MEDICINE; № 1.80 (2017); 179-184
МЕДИЦИНА НЕОТЛОЖНЫХ СОСТОЯНИЙ; № 1.80 (2017); 179-184
МЕДИЦИНА НЕВІДКЛАДНИХ СТАНІВ; № 1.80 (2017); 179-184
МЕДИЦИНА НЕОТЛОЖНЫХ СОСТОЯНИЙ; № 1.80 (2017); 179-184
МЕДИЦИНА НЕВІДКЛАДНИХ СТАНІВ; № 1.80 (2017); 179-184
У статті розглядається проблема гіпертрофічної кардіоміопатії. Наведено клінічний випадок ефективності радіочастотної абляції в умов
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94f42d373d7031e0d752462df628023b
https://doi.org/10.22141/2224-0586.1.80.2017.94471
https://doi.org/10.22141/2224-0586.1.80.2017.94471
Publikováno v:
Cureus. 14(6)
Significant progress has been achieved in treating patients with onco-hematological diseases, including chronic myeloid leukemia (CML). This is primarily associated with the development of targeted therapy involving tyrosine kinase inhibitors (TKIs),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2285be69d1e78a27cb83f1d9f00f4ea3
https://pubmed.ncbi.nlm.nih.gov/35812557
https://pubmed.ncbi.nlm.nih.gov/35812557
Publikováno v:
European Heart Journal: Case Reports
Background Cardiac resynchronization therapy (CRT) is an option for treatment for chronic heart failure (HF) associated with left bundle branch block (LBBB). Patients with HF and right bundle branch block (RBBB) have potentially worse outcomes in com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0968f33707d8edc5e484d88ada018bcd
https://doi.org/10.1093/ehjcr/ytab277
https://doi.org/10.1093/ehjcr/ytab277
Publikováno v:
Heart Rhythm. 18:S95
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14296f92873a017b538d563f15a03563
https://doi.org/10.1016/j.hrthm.2021.06.253
https://doi.org/10.1016/j.hrthm.2021.06.253
Publikováno v:
Cureus
The tyrosine kinase inhibitor (TKI) imatinib in rare cases can cause acute toxic hepatitis, hepatic failure, and death. Currently, the choice of further chronic myeloid leukemia (CML) therapy in patients after acute hepatotoxicity is still a difficul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cde0e7962f4f59f1098e713857a3028e
https://doi.org/10.7759/cureus.4411
https://doi.org/10.7759/cureus.4411
Autor:
Larysa Zhuravlyova, Iryna Dyagil, Iryna Dmytrenko, Dmytro Lopin, Kuznetsov Igor, Nataliia Lopina, Dmytro Hamov
Publikováno v:
Cureus
The introduction of imatinib has substantially changed the approaches to the therapy of chronic myeloid leukemia. However, this drug can cause hepatic failure and death in rare cases. This report describes a clinical case of acute, toxic imatinib-ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cefa7944fa7cc39911c635e193a1b5b
http://europepmc.org/articles/PMC6188217
http://europepmc.org/articles/PMC6188217
Publikováno v:
European Heart Journal Case Reports; Aug2021, Vol. 5 Issue 8, p1-7, 7p